Corticotrophin-releasing hormone binding protein in the basolateral amygdala: divergent roles in cocaine and opioid addiction like behaviors

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Addiction Neuroscience

• Publication date

  2025-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.addicn.2025.100221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence

  2023cited by this paper
• Single-nucleus genomics in outbred rats with divergent cocaine addiction-like behaviors reveals changes in amygdala GABAergic inhibition

  2023cited by this paper
• Strain and sex-related behavioral variability of oxycodone dependence in rats.

  2023cited by this paper
• Cocaine Exposure Increases Excitatory Synaptic Transmission and Intrinsic Excitability in the Basolateral Amygdala in Male and Female Rats and across the Estrous Cycle

  2023cited by this paper
• Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders.

  2022cited by this paper
• Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

  2022cited by this paper
• Large-scale characterization of cocaine addiction-like behaviors reveals that escalation of intake, aversion-resistant responding, and breaking-points are highly correlated measures of the same construct

  2021cited by this paper
• Interneuron Types and Their Circuits in the Basolateral Amygdala

  2021cited by this paper
• Trends and correlates of cocaine use among adults in the United States, 2006-2019.

  2021cited by this paper
• Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats

  2020cited by this paper
• Nociceptin attenuates the escalation of oxycodone self-administration by normalizing CeA–GABA transmission in highly addicted rats

  2020cited by this paper
• Personalizing the Treatment of Substance Use Disorders.

  2020cited by this paper
• Single-nucleus transcriptome analysis reveals cell type-specific molecular signatures across reward circuitry in the human brain

  2020cited by this paper
• Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction.

  2019cited by this paper
• Sex differences in oral oxycodone self‐administration and stress‐primed reinstatement in rats

  2019cited by this paper
• Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender

  2019cited by this paper
• Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential — United States, 2003–2017

  2019cited by this paper
• Association between stress pathway gene (CRHR1⧹CRHBP) polymorphisms and heroin dependence.

  2018cited by this paper
• Scrublet: computational identification of cell doublets in single-cell transcriptomic data

  2018cited by this paper
• Sex differences in circuits activated by corticotropin releasing factor in rats

  2018cited by this paper
• Sex differences in cocaine self-administration behaviour under Long Access versus Intermittent Access conditions

  2018cited by this paper
• The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  2018cited by this paper
• SCANPY: large-scale single-cell gene expression data analysis

  2018cited by this paper
• Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction

  2017cited by this paper
• Prefrontal Cortex Drives Distinct Projection Neurons in the Basolateral Amygdala.

  2017cited by this paper
• Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans

  2017cited by this paper
• From Structure to Behavior in Basolateral Amygdala-Hippocampus Circuits

  2017cited by this paper
• Inhibitory Gating of Basolateral Amygdala Inputs to the Prefrontal Cortex

  2016cited by this paper
• Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

  2016cited by this paper
• Defining the role of corticotropin releasing factor binding protein in alcohol consumption

  2016cited by this paper
• Understanding opioid reward.

  2015cited by this paper
• The Corticotropin Releasing Hormone-1 (CRH1) Receptor Antagonist Pexacerfont in Alcohol Dependence: A Randomized Controlled Experimental Medicine Study

  2015cited by this paper
• Corticotropin releasing factor: a key role in the neurobiology of addiction.

  2014cited by this paper
• Future pharmacological treatments for substance use disorders

  2014cited by this paper
• Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice.

  2012cited by this paper
• Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.

  2012cited by this paper
• Neurobiology of the incubation of drug craving.

  2011cited by this paper
• Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder

  2010cited by this paper
• Neurocircuitry of Addiction

  2010cited by this paper
• Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?

  2009cited by this paper
• A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.

  2008cited by this paper
• Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons.

  2008cited by this paper
• The Case for Chronic Disease Management for Addiction

  2008cited by this paper
• Major increases in opioid analgesic abuse in the United States: concerns and strategies.

  2006cited by this paper
• Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function

  2005cited by this paper
• The neural basis of addiction: a pathology of motivation and choice.

  2005cited by this paper
• Evidence for Addiction-like Behavior in the Rat

  2004cited by this paper
• Brain circuitry and the reinstatement of cocaine-seeking behavior

  2003cited by this paper
• Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons.

  2003cited by this paper
• Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats.

  2003cited by this paper
• Dissociable Effects of Lidocaine Inactivation of the Rostral and Caudal Basolateral Amygdala on the Maintenance and Reinstatement of Cocaine-Seeking Behavior in Rats

  2002cited by this paper
• Rewarding and Psychomotor Stimulant Effects of Endomorphin-1: Anteroposterior Differences within the Ventral Tegmental Area and Lack of Effect in Nucleus Accumbens

  2002cited by this paper
• Addiction and the brain: The neurobiology of compulsion and its persistence

  2001cited by this paper
• The neuropsychological basis of addictive behaviour.

  2001cited by this paper
• Dissociation of Primary and Secondary Reward-Relevant Limbic Nuclei in an Animal Model of Relapse

  2000cited by this paper
• Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine.

  1997cited by this paper
• Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

  1996cited by this paper

• No citing papers are available for this paper.